Public-registry site landscape for NCT03858972, a Breast Cancer study sponsored by Odonate Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03858972 (registry record) |
| Sponsor | Odonate Therapeutics, Inc. |
| Condition(s) | Breast Cancer |
| Phase | PHASE2 |
| Listed sites | 25 |
| Site countries | United States, Australia, Canada, South Korea, Spain, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT03858972 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →